Type of Care:
Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Outpatient
Facility Type:
Outpatient mental health facility
Pharmacotherapies:
Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Trifluoperazine Aripiprazole Cariprazine Clozapine Lurasidone Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI
Treatment Approaches:
Cognitive behavioral therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale
Facility Operation (e.g., Private, Public):
State government
Special Programs/Groups Offered:
Young adults Seniors or older adults Clients with co-occurring mental and substance use disorders Clients who have experienced trauma Persons 18 and older with serious mental illness (SMI)
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
Metabolic syndrome monitoring Laboratory testing
Recovery Support Services:
Mentoring/peer support
Education and Counseling Services:
Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Children/Adolescents Young Adults Adults Seniors
Language Services:
Sign language services for the deaf and hard of hearing Spanish Other languages (excluding Spanish)
Facility Vaping Policy:
Vaping not permitted
Ancillary Services:
Assisted Outpatient Treatment Court-ordered outpatient treatment Family psychoeducation Psychosocial rehabilitation services Vocational rehabilitation services Suicide prevention services